Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sequence-specific binding of luzopeptin to DNA.

K R Fox1, H Davies, G R Adams

  • 1Department of Pharmacology, University of Cambridge, UK.

Nucleic Acids Research
|March 25, 1988
PubMed
Summary

Luzopeptin, an antitumor antibiotic, binds tightly to DNA, particularly at AT-rich regions. This binding may involve covalent complex formation and DNA cross-linking, differing from related drugs.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spatial Single-Cell Proteomics Reveals Molecular Trajectories Of Tangle-Bearing Neurons In Alzheimer's Disease.

bioRxiv : the preprint server for biology·2026
Same author

Distinct mechanistic pathways of early tauopathy revealed by <i>MAPT</i> mutations.

bioRxiv : the preprint server for biology·2026
Same author

Author Correction: ROBIN: Reference observatory of basins for international hydrological climate change detection.

Scientific data·2025
Same author

ROBIN: Reference observatory of basins for international hydrological climate change detection.

Scientific data·2025
Same author

Recording of suspected adverse drug reaction reporting in veterinary free-text clinical narratives.

The Journal of small animal practice·2024
Same author

Transfusion of incompatible blood to a patient with alloanti-Sc1.

Immunohematology·2023

Area of Science:

  • Molecular Biology
  • Antimicrobial drug research
  • DNA-drug interactions

Background:

  • Luzopeptin is an antitumor antibiotic with potential DNA-binding properties.
  • Understanding DNA-drug interactions is crucial for developing new cancer therapies.
  • Related compounds like echinomycin exhibit DNA intercalation.

Purpose of the Study:

  • To investigate the DNA binding characteristics of luzopeptin.
  • To determine the sequence selectivity of luzopeptin binding to DNA.
  • To compare luzopeptin's binding with that of echinomycin.

Main Methods:

  • Binding assays using five DNA fragments with varying base compositions.
  • Nondenaturing polyacrylamide gel electrophoresis to assess DNA mobility.
  • DNAase I and micrococcal nuclease footprinting to identify binding sites.
  • Comparison with echinomycin binding properties.

Main Results:

  • Luzopeptin forms a tight complex with DNA, potentially covalent, causing reduced mobility and cross-linking.
  • The drug shows preferential binding to alternating A-T rich regions, but no specific consensus sequence was identified.
  • DNA is largely protected from enzymatic digestion at moderate concentrations.
  • Luzopeptin induces DNAase I cleavage at both AT and GC-rich sites.
  • Binding characteristics differ significantly from echinomycin.

Conclusions:

  • Luzopeptin exhibits unique DNA binding properties, including potential covalent complex formation and cross-linking.
  • Sequence selectivity favors AT-rich regions, but broader binding occurs.
  • Luzopeptin represents a distinct class of DNA-binding agents compared to echinomycin.

Related Experiment Videos